✦ LIBER ✦

Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia

✍ Scribed by Adam Gater; Louise Heron; Linda Abetz-Webb; John Coombs; Jeff Simmons; François Guilhot; Delphine Rea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient adherence to tyrosine kinase inh

✍ Elias J. Jabbour; Hagop Kantarjian; Lina Eliasson; A. Megan Cornelison; David Ma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

Dual tyrosine kinase inhibitors in chron

✍ Martinelli, G; Soverini, S; Rosti, G; Baccarani, M 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 322 KB

Second-generation tyrosine kinase inhibi

✍ Ronan Swords; Yesid Alvarado; Jorge Cortes; Francis J. Giles 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 145 KB

Profiling chronic myeloid leukemia patie

✍ Efficace, Fabio; Rosti, Gianantonio; Cottone, Francesco; Breccia, Massimo; Casta 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 732 KB

SP 108 Resistance to tyrosine kinase inh

✍ T. Lion 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Importance of adherence to BCR-ABL tyros

✍ de Almeida, Maria Helena; Fogliatto, Laura; Couto, Dulce 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 170 KB